A case of clinical complete response of colorectal liver metastasis following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab-Reference-Cited by-同舟云学术

A case of clinical complete response of colorectal liver metastasis following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab

Published:2018-08-21 Issue:2 Volume:26 Page:101-104
ISSN:1344-6835
Container-title:Annals of Cancer Research and Therapy
language:en
Short-container-title:Ann. Cancer Res. Therap.

Author:

Azuhata Takeo¹²,Shibata Masahiko¹³⁴,Nakamura Kazuhiro¹,Kawano Daisuke¹,Terakado Yoshinori¹,Azuhata Izumi¹,Sakurai Atsushi¹²,Yamada Takeshi¹,Sugita Kyouichi¹,Tomita Ryouichi¹,Tsuyama Yoshiro¹,Tanjoh Katsuhisa¹²,Azuhata Setsuo¹

Affiliation:

1. Seitokai Azuhata hospital

2. Department of Acute Medicine, Nihon University School of Medicine

3. Department of Advanced Cancer Immunotherapy, Fukushima Medical University

4. Department of Gastrointestinal Tract Surgery, Fukushima Medical University

Publisher

The Japanese Society of Strategies for Cancer Research and Therapy

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

https://www.jstage.jst.go.jp/article/acrt/26/2/26_101/_pdf

Reference15 articles.

1. 1) Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. (2012) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 17: 1-29. DOI: 10.1007/s10147-011-0315-2

2. 2) Steele G Jr, Ravikumar TS (1989) Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210: 127-138. DOI: 10.1097/00000658-198908000-00001

3. 3) Kato T, Shimamoto Y, Uchida J, Ohshimo H, Abe M, Shirasaka T and Fukushima M (2001) Possible regulation of 5-fluorouracil-induced neuro-and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil. Anticancer Res 21: 1705-1712.

4. 4) Yamada Y, Tahara M, Miya T, Satoh T, Shirao K, Shimada Y, Ohtsu A, Sasaki Y and Tanigawa Y (2008) Phase I/II study of oxaliplatin with S-1 as first-line therapy for patients with metastatic colorectal cancer. Br J Cancer 98: 1034-1038.

5. 5) Zhang J, Chung K, Zergebel C, Urrea P, Quinones M and Saltz L (2007) Phase I study of oral S-1 in combination of oxaliplatin and bevacizumab in patients with advanced solid tumors. J Clin Oncol ASCO Annual meeting Part I. 25 (suppl) 4091.